Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Consolidation Chemotherapy After Auto-HSCT for R/R Lymphoma
NCT02306837Phase 2Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Sep 2014
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan, cyclophosphamide, etoposide in lymphoma, sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.
02
Drugs
busulfancyclophosphamideetoposide
03
Conditions
lymphoma
Beyond the preview
Go deeper on NCT02306837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02306837.